U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07499999) titled 'Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer' on March 24.
Brief Summary: The goal of this research study is to evaluate the efficacy and safety of low-dose exemestane versus low-dose tamoxifen in post-menopausal women at high risk for breast cancer.
The names of the study drugs involved in this study are:
* Exemestane (a type of steroidal aromatase inhibitor)
* Tamoxifen (a type of selective estrogen receptor modulator)
Study Start Date: Sept. 09, 2026
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Ductal Carcinoma
Estrogen-recep...